Patents by Inventor Anna Portell Bueso

Anna Portell Bueso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of beta-sitosterol
    Patent number: 11591363
    Abstract: The present invention relates to a cocrystal of beta-sitosterol or a pharmaceutically acceptable ester thereof or an edible acceptable ester thereof and an organic carboxylic acid coformer, an hydrate crystal form of beta-sitosterol having 1.25 molecules of water per molecule of beta-sitosterol and a combination that comprises a cocrystal of beta-sitosterol and an organic carboxylic acid; and the hydrate crystal form of beta-sitosterol having 1.25 molecules of water per molecule of beta-sitosterol. It also relates to processes for their preparation, and compositions containing them, as well as their use as a medicament or dietary supplement or functional food, and in particular in the prophylaxis and/or treatment of a disease or conditions that involves an alteration of lipid metabolism, circulating levels of lipids in the blood and/or lipid composition in tissues and organs.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 28, 2023
    Assignees: CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L., ALIMENTOMICA, S.L.
    Inventors: Rafel Prohens López, Rafael Barbas Cañero, Anna Portell Bueso, Mariona Palou March, Francisca Serra Vich, Andreu Palou March
  • CRYSTALLINE FORMS OF BETA-SITOSTEROL
    Publication number: 20200207801
    Abstract: The present invention relates to a cocrystal of beta-sitosterol or a pharmaceutically acceptable ester thereof or an edible acceptable ester thereof and an organic carboxylic acid coformer, an hydrate crystal form of beta-sitosterol having 1.25 molecules of water per molecule of beta-sitosterol and a combination that comprises a cocrystal of beta-sitosterol and an organic carboxylic acid; and the hydrate crystal form of beta-sitosterol having 1.25 molecules of water per molecule of beta-sitosterol. It also relates to processes for their preparation, and compositions containing them, as well as their use as a medicament or dietary supplement or functional food, and in particular in the prophylaxis and/or treatment of a disease or conditions that involves an alteration of lipid metabolism, circulating levels of lipids in the blood and/or lipid composition in tissues and organs.
    Type: Application
    Filed: June 22, 2018
    Publication date: July 2, 2020
    Applicants: Center for Intelligent Research in Crystal Engineering, S.L., AlimenTomica, S.L.
    Inventors: Rafel PROHENS LÓPEZ, Rafael BARBAS CAÑERO, Anna PORTELL BUESO, Mariona PALOU MARCH, Francisca SERRA VICH, Andreu ñ PALOU MARCH
  • Polymorphs of Suberoylanilide Hydroxamic Acid
    Publication number: 20110313044
    Abstract: The present invention is directed to a novel form of suberoylanilide hydroxamic acid and the processes for its preparation.
    Type: Application
    Filed: June 16, 2011
    Publication date: December 22, 2011
    Applicant: URQUIMA S.A.
    Inventors: Xavier Vila Tusell, Cristina Puigjaner Vallet, Rafel Prohens López, Anna Portell Bueso, Ismael Valverde Martin